Alligator Bioscience Ab Quote - 0RK9

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

23.00

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

23.00 52 Week Range 23.00

Market Cap

15.133B

Previous Close

23.00

Open

Last Trade

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

9,512

Shares Outstanding

657,954,000

Dividend Yield

PE Ratio

-1.32

Earnings Per Share (EPS)

-0.38

Revenue

59.27M

Net Profit

-248.59M

Sector

Noncomml Resh Organizations

Industry

Noncomml Resh Organizations

Website

www.alligatorbioscience.se

Headquarters

Lund, Swe

Founded

Alligator Bioscience Ab is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker 0RK9. The last closing price for Alligator Bioscience Ab was SEK23. Over the last year, Alligator Bioscience Ab shares have traded in a share price range of SEK 23.00 to SEK 23.00.

Alligator Bioscience Ab currently has 657,954,000 shares outstanding. The market capitalization of Alligator Bioscience Ab is SEK15.13 billion. Alligator Bioscience Ab has a price to earnings ratio (PE ratio) of -1.32.

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	23	23	23	0	0	DE
4	23	23	23	13062	23	DE
12	23	23	23	9512	23	DE
26	23	23	23	4761	23	DE
52	23	23	23	3594	23	DE
156	23	23	23	2006	23	DE
260	23	23	23	2019	23	DE

0RK9 - Frequently Asked Questions (FAQ)

What is the current Alligator Bioscience Ab share price?

The current share price of Alligator Bioscience Ab is SEK 23.00

How many Alligator Bioscience Ab shares are in issue?

Alligator Bioscience Ab has 657,954,000 shares in issue

What is the market cap of Alligator Bioscience Ab?

The market capitalisation of Alligator Bioscience Ab is SEK 15.13B

What is the 1 year trading range for Alligator Bioscience Ab share price?

Alligator Bioscience Ab has traded in the range of SEK 23.00 to SEK 23.00 during the past year

What is the PE ratio of Alligator Bioscience Ab?

The price to earnings ratio of Alligator Bioscience Ab is -1.32

What is the cash to sales ratio of Alligator Bioscience Ab?

The cash to sales ratio of Alligator Bioscience Ab is 5.55

What is the reporting currency for Alligator Bioscience Ab?

Alligator Bioscience Ab reports financial results in SEK

What is the latest annual turnover for Alligator Bioscience Ab?

The latest annual turnover of Alligator Bioscience Ab is SEK 59.27M

What is the latest annual profit for Alligator Bioscience Ab?

The latest annual profit of Alligator Bioscience Ab is SEK -248.59M

What is the registered address of Alligator Bioscience Ab?

The registered address for Alligator Bioscience Ab is MEDICON VILLAGE, SCHEELEVAGEN 2, LUND, 223 81

What is the Alligator Bioscience Ab website address?

The website address for Alligator Bioscience Ab is www.alligatorbioscience.se

Which industry sector does Alligator Bioscience Ab operate in?

Alligator Bioscience Ab operates in the NONCOMML RESH ORGANIZATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCFTheracryf Plc	0.725p (38.10%)	7.56M
NMTNeometals Ltd	3.50p (27.27%)	346.81k
SCHOScholium Group Plc	44.00p (25.71%)	30.65k
FABFusion Antibodies Plc	10.15p (24.54%)	3.34M
PYXPyx Resources Limited	3.49p (22.24%)	8.43k
TM1Technology Minerals Plc	0.125p (-24.24%)	37.21M
QUIZQuiz Plc	0.70p (-18.60%)	3.67M
SYMESupply@me Capital Plc	0.003p (-17.81%)	168.35M
OBDOxford Biodynamics Plc	1.20p (-14.29%)	827.83k
ZENZenith Energy Ltd.	5.25p (-13.93%)	5.39M
TRPTower Resources Plc	0.0395p (5.33%)	539.51M
CPXCap-xx Limited	0.1825p (1.39%)	494M
NTVONativo Resources Plc	0.0019p (0.00%)	320.16M
DGIDg Innovate Plc	0.0225p (-13.46%)	208.21M
ENETEthernity Networks Ltd	0.1125p (2.27%)	207.56M